Singlera raises $60M series A+ round

Singlera Genomics Inc. (La Jolla, Calif.) raised $60 million on March 27 in a series A+ round led by China-based investors Green Pine Capital Partners and Prosperico Ventures. UCF Medical Investment, Jointown Pharmaceutical Group, Lilly Asia Ventures and other undisclosed investors also participated.

Singlera develops non-invasive genomic tests with a focus on diagnostic tests for early stage cancer. Its technologies include single cell sequencing, DNA methylation and bioinformatics...